Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

WGS - GeneDx Holdings Corp.

IEX Last Trade
77.38
38.610   49.897%

Share volume: 0
Last Updated: Tue 24 Dec 2024 06:24:49 PM CET

PREVIOUS CLOSE
CHG
CHG%
$38.77
38.61
99.59%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Historical prices Events Documents Notes Dividends
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0   0%
1 Month
-3.80%
3 Months
110.10%
6 Months
184.04%
1 Year
2,497.32%
2 Year
31,699.51%
Key data
Stock price
$77.38
P/E Ratio 
-7.33
DAY RANGE
$38.77 - $76.54
EPS 
-$3.79
52 WEEK RANGE
$2.71 - $89.11
52 WEEK CHANGE
$2,578.20
MARKET CAP 
860.333 M
YIELD 
N/A
SHARES OUTSTANDING 
26.936 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
10/28/2024
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$579,614
AVERAGE 30 VOLUME 
$512,350
Company detail
CEO: Katherine A. Stueland
Region: US
Website: sema4.com
Employees: 1,200
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry:
Sector:

Sema4 Holdings Corp. operates as a health information company that enhances diagnosis, treatment, and prevention of disease through data. The company provides Centrellis, an AI-driven health intelligence platform that delivers comprehensive insights to biopharma to accelerate the drug discovery, development, and commercialization life-cycle.

Recent news